Medical Supplies and Services News

Diazyme receives FDA 510(k) clearance for its isoform‑independent Lipoprotein(a) Molarity Assay, improving standardized cardiovascular risk assessment.

NETANYA, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE), a company that develops and acquires technologies for defense, security, and first-response markets, today...

EssilorLuxottica and Applied Materials Join Forces to Advance Augmented Reality Optics Platforms for Next-Generation Smart Glasses Joint development agreement aims to accelerate commercialization of...

EssilorLuxottica et Applied Materials s’unissent pour faire progresserles dispositifs optiques de réalité augmentéedestinés aux nouvelles générations de lunettes intelligentes L'accord de...

EssilorLuxottica e Applied Materials insieme per sviluppare sistemi ottici di realtà aumentata per gli smart glasses del futuro L'accordo di sviluppo congiunto mira ad accelerare l’introduzione sul...

Miami, Florida, June 16, 2026 (GLOBE NEWSWIRE) -- There is a quiet conversation happening in fitting rooms, group texts, and medical offices all over the country that rarely surfaces publicly....

First Tranche Closing (50%) of Botanico Transaction Expands International Platform with Exclusive Access to U.S. Genetics, Premium Brands and Advanced AI-Driven Technologies; Company Reports Growing...

SINGAPORE, June 15, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“CUPR” or “the Company”), a biomedical company developing and marketing products for the chronic...

苏黎世, June 13, 2026 (GLOBE NEWSWIRE) -- 随着过敏性疾病持续影响全球数亿人口，并给医疗系统带来日益沉重的压力，European Academy of Allergy and Clinical Immunology (EAACI) 呼吁确立一项全新的全球健康愿景——“零愿景”：打造没有过敏与哮喘负担的未来。 这一愿景将成为 2026 年 6 月 12 日至...

蘇黎世, June 13, 2026 (GLOBE NEWSWIRE) -- 隨著過敏疾病持續對全球數以億計人口帶來影響，亦為醫療系統增添壓力，European Academy of Allergy and Clinical Immunology (EAACI) 呼籲在全球健康領域樹立全新目標：實現「零願景」的未來，消除過敏症與哮喘病帶來的健康負擔。 這個願景將成為 2026 年 EAACI...